Equities

Acadia Healthcare Company Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Acadia Healthcare Company Inc

Actions
  • Price (EUR)20.40
  • Today's Change0.600 / 3.03%
  • Shares traded14.00
  • 1 Year change-23.31%
  • Beta0.7312
Data delayed at least 15 minutes, as of Mar 05 2026 15:32 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Acadia Healthcare Company Inc had net income fall from a gain of 255.61m to a loss of 1.10bn despite a 5.04% increase in revenues from 3.15bn to 3.31bn. An increase in the selling, general and administrative costs as a percentage of sales from 64.72% to 65.87% was a component in the falling net income despite rising revenues.
Gross margin--
Net profit margin-32.96%
Operating margin-28.25%
Return on assets-19.02%
Return on equity-43.91%
Return on investment-21.68%
More ▼

Cash flow in USDView more

In 2025, Acadia Healthcare Company Inc increased its cash reserves by 74.62%, or 56.94m. Cash Flow from Financing totalled 481.25m or 14.53% of revenues. In addition the company generated 131.90m in cash from operations while cash used for investing totalled 556.21m.
Cash flow per share-9.93
Price/Cash flow per share--
Book value per share21.55
Tangible book value per share6.15
More ▼

Balance sheet in USDView more

Acadia Healthcare Company Inc has a Debt to Total Capital ratio of 53.99%, a lower figure than the previous year's 61.52%.
Current ratio1.55
Quick ratio1.54
Total debt/total equity1.29
Total debt/total capital0.5399
More ▼

Growth rates in USD

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-539.20
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.